CS logo
small CS logo
Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology

Kaoisung, Taiwan
General hospital in Kaohsiung
No. 123號, Dapi Rd, Niaosong District, Kaohsiung City, 833

About Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


"Kaohsiung CGMH NeuroScience Lab MRI and PET schedule"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


During the past decade, Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are "Diffuse Large B-cell Lymphoma" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


Most popular intervention types in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab Matching Placebo" (1 trials), "Gemcitabine" (1 trials), "Glofitamab" (1 trials) and "Lenalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


The vast majority of trials in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology" are 3 trials for "All" genders.

Clinical Trials Status at Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology


Currently, there are NaN active trials in "Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation - Kaohsiung; Oncology; Division of Hematology-Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".